Workup for a 14-Year-Old with Intermittent Hypoglycemia and Normal HbA1c
This adolescent requires a comprehensive evaluation to identify the underlying cause of hypoglycemia, focusing on obtaining a critical sample during a symptomatic episode to measure plasma glucose, insulin, C-peptide, proinsulin, and beta-hydroxybutyrate, while simultaneously screening for endocrine disorders and considering early autoimmune type 1 diabetes. 1
Confirm True Hypoglycemia
- Verify that plasma glucose is <70 mg/dL during symptomatic episodes, as this threshold confirms true hypoglycemia rather than CGM artifact or normal glycemic variability 1
- The CGM data should be correlated with fingerstick or laboratory glucose measurements, as CGM accuracy can vary particularly in the hypoglycemic range (MARD up to 31.9% for glucose <70 mg/dL in some systems) 2
- Document the timing of hypoglycemic episodes (fasting vs. postprandial) as this guides differential diagnosis 1
Obtain Critical Sample During Hypoglycemia
The most diagnostically valuable step is obtaining blood work during an actual hypoglycemic episode (plasma glucose <70 mg/dL), which should include: 1
- Plasma glucose (laboratory confirmation, not just CGM or fingerstick)
- Insulin level
- C-peptide
- Proinsulin
- Beta-hydroxybutyrate (ketones)
This "critical sample" distinguishes between hyperinsulinemic causes (elevated insulin/C-peptide with suppressed ketones) versus counter-regulatory hormone deficiencies (low insulin with elevated ketones) 1
Screen for Endocrine Disorders
Evaluate for hormonal deficiencies that impair glucose counter-regulation: 1
- Morning cortisol and ACTH to screen for adrenal insufficiency (Addison disease), which is a life-threatening cause of hypoglycemia 1
- TSH and free T4 to exclude hypothyroidism, which can contribute to hypoglycemia 1
- IGF-1 level if growth velocity is abnormal or if there are other signs suggesting growth hormone deficiency 1
Evaluate for Early Type 1 Diabetes
Test pancreatic autoantibodies (GAD65, IA-2, ZnT8, insulin autoantibodies) to exclude evolving autoimmune type 1 diabetes, as intermittent hypoglycemia can occur in the early stages before overt hyperglycemia develops 1
- Early type 1 diabetes can present with reactive or postprandial hypoglycemia due to dysregulated insulin secretion 1
- A normal HbA1c does not exclude early-stage type 1 diabetes, as HbA1c reflects average glucose over 2-3 months and may miss intermittent patterns 2
Consider Metabolic/Genetic Causes
If hypoglycemia occurs primarily with fasting, obtain an acylcarnitine profile to screen for fatty acid oxidation disorders, which prevent appropriate ketone production during fasting 1
- Hereditary fructose intolerance should be considered if symptoms correlate with fructose ingestion 1
Immediate Safety Measures
Prescribe a glucagon emergency kit (1 mg dose for patients >25 kg or ≥6 years old) for severe hypoglycemic episodes, to be administered subcutaneously or intramuscularly by caregivers 3
- Educate the patient and family on recognizing hypoglycemia symptoms and treating with 15-20 grams of fast-acting carbohydrate 1
- Instruct caregivers to call emergency services immediately after administering glucagon 3
Ongoing Monitoring Strategy
- Continue CGM use to capture patterns and frequency of hypoglycemia, as this technology helps identify episodes that might otherwise be missed 2, 1
- Review CGM data for patterns: nocturnal hypoglycemia, exercise-related hypoglycemia, or postprandial reactive hypoglycemia 1
- Document any triggers such as prolonged fasting, specific foods, or physical activity 1
Critical Pitfall to Avoid
Do not assume this is benign reactive hypoglycemia without completing the diagnostic workup, as serious underlying conditions (adrenal insufficiency, insulinoma, early type 1 diabetes) can present with intermittent hypoglycemia and normal HbA1c 1